Register entry
CHENGDA PHARMACEUTICALS Co., LTD.
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- China
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| CHENGDA PHARMACEUTICALS Co., LTD. | No. 36 Huanghe Road, Huimin Subdistrict,, Jiashan Jiaxing, 314100, China (CHN) | Active ingredient (API) manufacture | 3004248447530737899 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Levocarnitine | powder | 58116-010BULK INGREDIENT |
Compare
Comparable companies in China
- Qingdao Biopeptek Co Ltd1 site · 110 NDC
- Zhejiang Ausun Pharmaceutical Co., Ltd.1 site · 55 NDC
- Hubei Gedian Humanwell Pharmaceutical Co., Ltd1 site · 31 NDC
- Shandong New Time Pharmaceutical Co., Ltd.1 site · 29 NDC
- Anqiu Lu'an Pharmaceutical Co., Ltd.1 site · 27 NDC
- Hainan Poly Pharm. Co., Ltd.1 site · 27 NDC
- Shenzhen Alvantis Pharma Co., Ltd.1 site · 27 NDC
- El-Peptido (Shanghai) Biopharmaceutical Co., Ltd1 site · 25 NDC
- Amphastar Nanjing Pharmaceuticals, Inc.1 site · 24 NDC
- Zhejiang Apeloa Jiayuan Pharmaceutical Co Ltd1 site · 23 NDC
Enquiry
Common questions
- Is CHENGDA PHARMACEUTICALS Co., LTD. FDA approved?
- CHENGDA PHARMACEUTICALS Co., LTD. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are CHENGDA PHARMACEUTICALS Co., LTD.'s drugs manufactured?
- The FDA register lists Jiashan Jiaxing. Registered operations: active ingredient (API) manufacture.
- What drugs does CHENGDA PHARMACEUTICALS Co., LTD. make?
- 1 product is listed under CHENGDA PHARMACEUTICALS Co., LTD. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.